DecisionDx-Melanoma Gene Expression Test Improves Risk Prediction Beyond Standard Staging
Data from nearly 1,900 SEER-linked patients show the test identifies meaningful survival differences within the same AJCC stage.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Melanoma |
Data from nearly 1,900 SEER-linked patients show the test identifies meaningful survival differences within the same AJCC stage.
Read MorePosted by CLP Edit Staff | Apr 3, 2026 | Company News |
The five-year agreement with MRIGlobal aims to enhance laboratory readiness and response for public health emergencies.
Read MorePosted by CLP Edit Staff | Apr 3, 2026 | Covid 19 |
PolyBio Research Foundation has launched a $1.35 million program at UCSF to compare and validate diagnostic tests for long COVID, aiming to address the lack of standardized clinical diagnostics in the field.
Read MorePosted by CLP Edit Staff | Apr 2, 2026 | Company News |
The multi-year collaboration combines kitted next-generation sequencing panels with a global laboratory network to improve turnaround times and support diagnostic programs.
Read MorePosted by CLP Edit Staff | Apr 2, 2026 | Prostate |
A new study validates a machine-learning platform that detects prostate cancer through biochemical patterns in urine samples.
Read More